University
of Bristol spin-out company CytoSeek has raised £3.5 million to accelerate the development of new cell therapies to treat solid tumours in cancer patients, based on the research of Adam Perriman, Professor of Bioengineering in the School of Cellular and Molecular Medicine. The funding round is led by Science Creates Ventures (SCV), a new Bristol based fund for science and engineering start-ups. Read the University’s press release.
